Pulmonary embolism registry study in Warsaw
Part of Blood & lymphatic, Heart & circulation, Lungs & breathing clinical trials.
This study keeps a registry (record) of people with a confirmed pulmonary embolism. Your information helps doctors better understand the condition and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a pulmonary embolism that has been confirmed by medical tests
- You can and will sign informed consent for the study
- If you do not provide consent, you cannot join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well certain scores, blood tests, and CT scan findings predict the severity of a pulmonary embolism (blood clot in the lungs). By joining, you may help doctors better understand and treat this condition.
This is a registry study that collects information from people diagnosed with takotsubo syndrome. It helps researchers better understand the condition and may improve care in the future.
This study builds a database of people with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension. It may help doctors better understand these conditions in the Polish population and improve future care decisions.
This trial is a registry that collects information about people with a recent lung blood clot diagnosed by CT scan. It particularly focuses on higher-risk cases to better understand outcomes and care in the first 2 weeks after symptoms start.
This study looks at different ways to manage pulmonary embolism, a blood clot in the lungs. It aims to find the best treatment to help patients recover better.
This trial looks at how people do after an acute pulmonary embolism (a blood clot in the lungs). It aims to understand real-world outcomes over follow-up and may help improve how care teams track patients after treatment.
Hear when a new Acute Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.